Biosynthesis of methylmercury discovered


 

While we all know mercury is poisonous it is methylmercury, the organic form, that bioaccumulates in food webs and is highly toxic. It's been acknowledged for years that methylmercury is produced by microorganisms far down the food chain, but what has not been known is how they do it. US-based researchers at Oak Ridge National Laboratory in Tennessee have now identified the genes, and hence the proteins, involved in mercury methylation and suggest that the pathway is common for all mercury methylating microorganisms.

Using gene deletion, Jerry Parks' team showed that two genes are key components of bacterial mercury methylation, relating to a corrinoid protein that acts as a methyl carrier and a ferredoxin protein that reduces the corrinoid protein's cofactor. What is still not apparent, however, is why these bacteria have evolved to methylate mercury at all.


Related Content

Chemistry World podcast - July 2013

1 July 2013 Podcast | Monthly

news image

Hagan Bayley explains the scientific scope for 3D printing and Chad Mirkin introduces programmable DNA building blocks

Chemistry World podcast - March 2013

13 March 2013 Podcast | Monthly

news image

Mark Mascal talks about bio-derived chemicals, John Lindon introduces the Phenome Centre and the team cover the latest news

Most Read

Sun rises on new solar route to hydrogen

27 February 2015 Research

news image

Photocatalyst has solar-to-hydrogen conversion efficiency of 2% and points way to cheap production of the gas

The mothers of invention

24 February 2015 Managing Change

news image

Nina Notman profiles four researchers successfully balancing an academic career with family life

Most Commented

Sun rises on new solar route to hydrogen

27 February 2015 Research

news image

Photocatalyst has solar-to-hydrogen conversion efficiency of 2% and points way to cheap production of the gas

Hepatitis C drug patent challenged in Europe

19 February 2015 Business

news image

Campaign group says Gilead’s expensive blockbuster sofosbuvir is not innovative enough to warrant a patent